ArticleAntimicrobial agents and chemotherapy2023

Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling.

M T Chirehwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.